Experts suggest that this near-point-of-care molecular test can be implemented at the primary care level and at a lower cost.

Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected Mid-2026 and Topline Results from C-FORWARD Trial Outs ...

Opinion: Outrage over the CDC’s changes to its hepatitis B vaccine schedule is overblown, writes Del. Lauren Arikan.

Good afternoon, everyone, and welcome to the Atea Pharmaceuticals' Fourth Quarter 2025 Financial Results and Business Update Conference Call. [Operator Instructions] I would now like to turn the call ...

Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected ...

Denmark becomes the first EU country to eliminate mother-to-child transmission of HIV and syphilis through nationwide ...

Researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) have developed a world-first ...

Hepion Pharmaceuticals, Inc. (OTCQB:HEPA), a precision diagnostics company, today announced that it has in-licensed from ...

Chronic hepatitis B is a viral disease that affects the liver and greatly increases the risks of liver cirrhosis and ...

With the Philippines recording 32 deaths daily due to liver cancer, a group of hepatologists or doctors specializing in liver diseases has urged the government to establish a national liver center to ...

Liver enzymes help break down food and turn it into energy and nutritional elements, among other things. Elevated levels ...

Researchers at Tezpur University in India have identified a panel of circulating microRNAs in blood serum that may help distinguish gallbladder cancer from benign conditions, offering a potential ...